Elite Pharmaceuticals ELTP
OTC ELTP
$0.24 +0.00 (+0.00%)
As of: Oct 21, 2026 · 11:00 AM EDT

Elite Pharmaceuticals (ELTP) Non Operating Interest Expenses (2010 - 2026)

Updated

Elite Pharmaceuticals' Non Operating Interest Expenses was $73,103 in fiscal Q1 2027 (quarter ended Jun 30, 2026), down 54.0% from $158,926 a year earlier.

Analysis

Elite Pharmaceuticals (ELTP) Non Operating Interest Expenses (2010 - 2026) Analysis & Trends

On a trailing twelve-month basis, Elite Pharmaceuticals' Non Operating Interest Expenses was $503,342 through Jun 30, 2026, down 26.0% year-over-year; for FY2026 (ended Mar 31, 2026), it came in at $396,664, down 48.6% from FY2025.

  • Non Operating Interest Expenses shows a five-year compound annual growth rate of 8.8% (FY2021 to FY2026).
  • In earlier fiscal years, Non Operating Interest Expenses was $772,367 in FY2025 (+31.2%), $588,622 in FY2024 (-47.1%), $1.11 million in FY2023 (+480.1%) and $191,816 in FY2022 (-26.1%).
  • The fiscal Q1 2027 figure marks the lowest quarterly Non Operating Interest Expenses since fiscal Q4 2022.
  • Compared with a year earlier, Non Operating Interest Expenses was higher in 1 of the last six quarters, with an average decline of 18.7%.
  • The best year-over-year quarter for Non Operating Interest Expenses over five years was fiscal Q3 2023 (growth of 762.8%); the worst was fiscal Q2 2026 (a decline of 67.7%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Eli Lilly 1,163.48 Bn 1,132.06 Bn 19.71 Bn -
2 Johnson & Johnson 631.16 Bn 549.69 Bn 17.26 Bn 281.00 Mn
3 AbbVie 502.63 Bn 475.74 Bn 12.70 Bn -
4 Merck 378.53 Bn 332.91 Bn 12.21 Bn -
5 Novartis Ag 302.83 Bn 266.82 Bn 11.24 Bn 462.00 Mn
6 Astrazeneca 265.92 Bn 239.60 Bn 12.86 Bn 435.00 Mn
7 Amgen 240.87 Bn 196.27 Bn 7.24 Bn 673.00 Mn
8 Gilead Sciences 194.04 Bn 168.24 Bn 6.22 Bn 247.00 Mn
9 Pfizer 172.14 Bn 118.78 Bn 10.94 Bn -
10 Elite Pharmaceuticals 263.92 Mn 145.59 Mn 13.51 Mn 73,103.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 73,103.00
Sep 30, 2025 82,470.00
Jun 30, 2025 158,926.00
Mar 31, 2025 188,843.00
Dec 31, 2024 77,607.00
Sep 30, 2024 255,136.00
Jun 30, 2024 250,781.00
Mar 31, 2024 217,144.00
Dec 31, 2023 121,628.00
Sep 30, 2023 130,438.00
Jun 30, 2023 119,412.00
Mar 31, 2023 330,486.00
Dec 31, 2022 322,681.00
Sep 30, 2022 242,753.00
Jun 30, 2022 216,787.00
Mar 31, 2022 65,440.00
Dec 31, 2021 37,400.00
Sep 30, 2021 43,083.00
Jun 30, 2021 45,893.00
Mar 31, 2021 20,741.00
API Access

Elite Pharmaceuticals Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=ELTP&period=max&api_key=YOUR_API_KEY